Skip to main content
Online Only
HOPA Highlights, Breast Cancer
Advances in Breast Cancer Treatments: Are We Extending Patients’ Survival?
Meg Barbor, MPH
Meg Barbor, MPH
Read More
Online Only
HOPA Highlights
Role of Pharmacists in the Management of Chemotherapy-Induced Nausea and Vomiting
Meg Barbor, MPH
Meg Barbor, MPH
Read More
Online Only
HOPA Highlights
Translating Cancer Genetics into Clinical Practice
Meg Barbor, MPH
Meg Barbor, MPH
Read More
Online First
Editorial, COVID-19
Protecting Patients with Cancer During the COVID-19 Pandemic
Robert Mancini, PharmD, BCOP, FHOPA, Timothy G. Tyler, PharmD, FCSHP, FHOPA
Robert Mancini, PharmD, BCOP, FHOPA, and Timothy G. Tyler, PharmD, FCSHP, FHOPA
Read More
Chronic Lymphocytic Leukemia
Navigating Chronic Lymphocytic Leukemia (CLL): The Critical Importance of the First 90 Days
Read More
Editorial, HOPA Abstracts
HOP(A) Springs Eternal
Bryna Delman Ewachiw, PharmD, BCOP, Mark L. Zangardi, PharmD, BCOP
By Bryna Delman Ewachiw, PharmD, BCOP; Mark L. Zangardi, PharmD, BCOP
Read More
HOPA Abstracts, Lymphoma
A Pooled Safety Analysis of Loncastuximab Tesirine in Relapsed or Refractory DLBCL in the LOTIS Clinical Trial Program: Incidence, Onset, and Management of Myelosuppression
Abstract #CR01
Read More
HOPA Abstracts
Evaluation of Empiric Double Coverage with Tobramycin for Adult Patients with Febrile Neutropenia
Abstract #CR02
Read More
HOPA Abstracts, Gynecologic Cancers
Treatment Patterns, Real-World Outcomes, and Resource Use in Patients with Non–MSI-High or Mismatch Repair Proficient Advanced Endometrial Cancer
Abstract #CR03
Read More
HOPA Abstracts, Breast Cancer, CDK4/6 Inhibitors
Development and Implementation of a Pharmacist-Led Virtual Clinic Improve the Management of Patients with Metastatic Breast Cancer Receiving CDK4/6 Inhibitors
Abstract #CR04
Read More
Page 57 of 199
Results 561 - 570 of 1986